Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2013-005325-23Phase 2Active
Phase 2, randomised, double-blind trial of bupivacaine in hot flash (2 arms), sponsored by Rijnstate. Primary endpoint: Hot Flush Score. Started Mar 2014; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2013-005325-23.